首頁 > 市場調查報告書 > 醫療設備

病患監測行動醫療

市場調查報告書

商品編碼

1629830

全球穿戴式醫療設備市場 - 2024-2031

Global Wearable Medical Devices Market - 2024-2031

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2023年，全球穿戴式醫療設備市場規模達357億美元，預計2031年將達2,074.7億美元，2024-2031年預測期間複合年成長率為24.6%。

穿戴式醫療設備是醫療保健技術的重大進步，旨在即時監控健康指標。這些設備，從健身追蹤器到心電圖貼片等專用監視器，可提供有價值的健康見解並促進遠端患者監測，特別是在服務不足的地區。收集的資料可以直接傳輸給醫療保健提供者，從而增強臨床決策並可能改善患者的治療結果。然而，穿戴式醫療設備的快速普及引起了人們對使用者接受度、安全性和道德影響的擔憂。解決這些問題對於充分發揮其在現代醫療保健系統中的潛力至關重要。預計該市場將產生可觀的收入。

市場動態：

驅動程式和限制

慢性病盛行率不斷上升和健康意識增強

由於多種因素，全球使用的穿戴式醫療設備正在蓬勃發展，需求不斷增加；其中之一是糖尿病、心血管疾病、呼吸系統疾病等慢性疾病的盛行率不斷上升，需要持續監測和主動管理，而穿戴式裝置可以輕鬆滿足這項需求。舉例來說，糖尿病患者的血糖監測設備、心血管健康的心率監測設備；這些正在成為主要產品。此外，消費者健康意識的增強進一步促使穿戴式科技用於預防性護理。

世界各地的政府和醫療機構都在倡導使用這些設備來減少再入院率並改善患者的治療效果。它們還因與數位健康平台和行動應用程式的即時資料追蹤、分析和警報的關聯而變得更具吸引力。

例如，根據美國疾病管制與預防中心的數據，美國有 1.29 億人患有至少一種主要慢性疾病，包括心臟病、癌症、糖尿病、肥胖和高血壓。美國十大死亡原因中有五個與可預防和可治療的慢性病有關。在過去的二十年中，患病率穩步上升，並且預計這種趨勢將持續下去。越來越多的美國人患有多種慢性病，其中 42% 的人患有兩種或兩種以上，12% 的人患有至少五種慢性病。慢性病也對美國醫療保健系統產生重大影響，佔年度 4.1 兆美元支出的 90%。

這些設備，例如血糖監測儀、智慧手錶和健身追蹤器，可以幫助患者和醫療保健提供者有效地管理這些狀況。慢性病帶來的經濟負擔佔年度醫療保健支出的 90%，凸顯了對具有成本效益的解決方案的需求。慢性病盛行率的上升以及對多功能穿戴裝置的需求推動了全球的進步和市場擴張。

資料隱私和安全問題

由於資料隱私和安全問題，穿戴式醫療設備市場面臨挑戰。隨著大量敏感健康資料的產生和傳輸，人們開始擔心未經授權的存取、資料外洩和濫用個人健康資訊。網路安全威脅，特別是當設備透過物聯網互連時，對用戶信任構成挑戰。各地區缺乏標準化監管使情況更加複雜。由於隱私問題，消費者對採用這些技術猶豫不決，這可能會減緩市場成長。公司面臨越來越大的壓力，需要投資強大的安全協議並遵守不斷發展的法律框架。

Wearable medical devices are a significant advancement in healthcare technology, designed to monitor health metrics in real-time. These devices, ranging from fitness trackers to specialized monitors like ECG patches, provide valuable health insights and facilitate remote patient monitoring, especially in underserved areas. The data collected can be transmitted directly to healthcare providers, enhancing clinical decision-making and potentially improving patient outcomes. However, the rapid adoption of wearable medical devices raises concerns about user acceptance, security, and ethical implications. Addressing these issues is crucial for the full realization of their potential in modern healthcare systems. The market is projected to generate substantial revenue.

Market Dynamics: Drivers & Restraints

Growing Prevalence of Chronic Diseases and Health Awareness

Wearable medical devices used all over the world are highly prospering as their demand increases because of many factors; one of them is the incessantly growing prevalence of chronic diseases like diabetes, cardiovascular diseases, respiratory conditions, etc., which requires continuous monitoring and proactive management where wearable devices quite easily can cater to the need. To illustrate, glucose monitoring devices for diabetic patients, heart rate monitors for cardiovascular health; these are becoming staples. Also, increased health consciousness among consumers further induces the adoption of wearable technologies for preventive care.

Governments and healthcare organizations all over the world are advocating about these devices to reduce readmissions into hospitals and enhance patient outcomes. They also become more attractive with their association with digital health platforms and mobile applications for real-time data tracking, analysis, and alert.

For instance, according to Centers for Disease Control and Prevention, the US has 129 million people with at least one major chronic disease, including heart disease, cancer, diabetes, obesity, and hypertension. Five of the top 10 leading causes of death in the US are associated with preventable and treatable chronic diseases. Over the past two decades, prevalence has steadily increased, and this trend is expected to continue. An increasing proportion of Americans are dealing with multiple chronic conditions, with 42% having two or more and 12% having at least five. Chronic diseases also significantly impact the US healthcare system, accounting for 90% of annual $4.1 trillion expenditure.

These devices, such as glucose monitors, smartwatches, and fitness trackers, help patients and healthcare providers manage these conditions effectively. The financial burden of chronic diseases, accounting for 90% of annual healthcare expenditure, underscores the need for cost-effective solutions. The rising prevalence of chronic diseases and the need for multifunctional wearables drive advancements and market expansion worldwide.

Data Privacy and Security Concerns

The wearable medical device market faces challenges due to data privacy and security concerns. With the vast amount of sensitive health data generated and transmitted, concerns about unauthorized access, data breaches, and misuse of personal health information arise. Cybersecurity threats, particularly as devices become interconnected through IoT, pose a challenge to user trust. The lack of standardized regulations across regions further complicates the situation. Consumers are hesitant to adopt these technologies due to privacy concerns, potentially slowing market growth. Companies face increasing pressure to invest in robust security protocols and comply with evolving legal frameworks.

Segment Analysis

The global wearable medical devices market is segmented based on product type, application, end user and region.

Product type:

Diagnostic & Monitoring Devices segment is expected to dominate the wearable medical devices market share

The diagnostic & monitoring devices segment holds a major portion of the wearable medical devices market share and is expected to continue to hold a significant portion of the wearable medical devices market share during the forecast period.

The Global Wearable Medical Devices Market is certainly buoyed up and influencing the expansion and adoption of the various diagnostic and monitoring devices that feature prominently in it. Such devices are crafted, as the ultimate end purpose, for the real-time physiological and biometric data gathering to allow a continuous monitoring and early diagnosis of different health conditions.

Examples of such products include continuous glucose monitoring systems, ECG monitoring systems, pulse oximeters, and blood pressure monitoring systems. These systems are basically used for the management of most chronic conditions such as diabetes, cardiovascular diseases, and respiratory diseases. They enable the patients to keep a convenient and informative record of their own health metrics.

For instance, in October 2024, Samsung has launched the Galaxy Ring in India, a wearable device designed to enhance digital health through Galaxy AI. The sleek and compact device offers personalized health insights and tailored experiences. The Galaxy Ring is a significant step in active and autonomous health management, providing users with valuable guidance for healthier lifestyles. Its advanced sensors provide insights into users' lifestyle patterns, helping them manage their health goals.

Moreover, in June 2024, Elemind, a neurotech wellness company, has introduced a unique neurotechnology headband that enhances sleep performance by directing brainwaves out of wakeful patterns. The wearable device reduced the time to sleep in 76% of study participants by 48% and up to 74%.

Moreover, these enable healthcare providers to carry out the needed remoting of their patients leading to timely interventions and positive health outcomes. Advanced sensor-integrated, AI-driven analytics crammed in these devices will enhance the parameters while boosting their accuracy and predictive capability to provide actionable insight as well.

Application:

Remote Patient Monitoring segment is the fastest-growing segment in wearable medical devices market share

The remote patient monitoring segment is the fastest-growing segment in the wearable medical devices market share and is expected to hold the market share over the forecast period.

Remote Patient Monitoring is a fast-growing aspect of the global wearable medical devices market which needs lots of solutions regarding continuous work with healthcare access and management in places other than clinical environments. remote patient monitoring devices include wearable ECG monitors, glucose trackers, and respiratory sensors. It used to enable providers to monitor their patients' vital signs and chronic conditions in real time from anywhere. It mostly benefits elderly people, those whose mobility is challenged, and those suffering from chronic diseases that require frequent measurement by health care professionals. remote patient monitoring is a great growth opportunity for hospital readmissions, encourages patient engagement with the system, and provides early intervention in the event of abnormalities, which collectively improves health outcomes.

Moreover, rapid advancement of technologies such as telehealth applications and healthcare digitalization, along with the growing need for cost-effective solutions to reduce the burden on the healthcare systems, have significantly increased uptake of remote patient monitoring. this change in the trend will create a significant shift toward value-based care and make remote patient monitoring a critical and essential component of the growth seen in the global market for wearable medical devices.

Geographical Analysis

North America is expected to hold a significant position in the wearable medical devices market share

North America holds a substantial position in the wearable medical devices market and is expected to hold most of the market share.

North America is one of the prominent regions in the Global Wearable Medical Devices Market, and the following are the prime drivers for this. Chronic diseases such as diabetes, cardiovascular diseases, and obesity are prevalent in the region, giving rise to a considerable demand for such technologies where monitoring and management can be performed in real time. Rapid growth is also due to the higher adoption of digital health solutions and improved healthcare infrastructure. The high disposable income, along with the readiness of consumers to adopt advanced medical technologies, further push the use of such devices. Government initiatives to promote preventive healthcare and telemedicine encourage adoption as well.

For instance, in November 2024, Aktiia has launched its continuous blood pressure monitoring bracelet in Canada, marking its first market expansion outside Europe. The company's CEO, Raghav Gupta, praised Canada's collaborative healthcare environment for its ideal position to integrate innovative products. The launch aims to make it easier for millions of people to monitor their cardiovascular health, with smooth pathways for product adoption, clinical trials, and partnerships with healthcare providers across the country.

Europe is growing at the fastest pace in the wearable medical devices market

Europe holds the fastest pace in the wearable medical devices market and is expected to hold most of the market share due to the rise in chronic diseases like diabetes, cardiovascular conditions, and obesity, necessitating continuous health monitoring. The region's established healthcare infrastructure and high healthcare expenditure enable advanced wearable technologies adoption. The growing aging population and awareness of preventive healthcare support market growth. Favourable regulatory frameworks and increased investment in research contribute to innovation. Smartphone penetration and wireless connectivity have made it easier for patients and healthcare professionals to integrate wearable devices into their routines.

For instance, in June 2023, Lithuanian high-tech company Teltonika has launched TeltoHeart, a multifunctional smart medical wristband designed to help people with heart rhythm problems. The device, created by Arvydas Paukstys, was inspired by a highly accurate algorithm developed by Kaunas University of Technology and Vilnius University. Teltonika agreed to license this unique and patented technology, marking the beginning of a long road to developing a global gadget with exceptional technical capabilities.

Competitive Landscape

The major global players in the wearable medical devices market include Koninklijke Philips N.V.; Fitbit (Google); Garmin Ltd.; Medtronic; Omron; Withings; VitalConnect; Polar Electro; Sotera, Inc.; INVIZA Corporation; Dexcom, Inc.; GE HealthCare; CONTEC MEDICAL SYSTEMS CO., LTD; Nanowear Inc. among others.

Emerging Players

The emerging players in the wearable medical devices market include Nuubo, Activinsights Ltd, Intelesens Ltd , Polar Electro Oy and among others

Key Developments

In January 2024, Fitbit and Quest Diagnostics have partnered to study the use of wearable devices to improve metabolic health, which affects the risk of developing diseases like diabetes and heart disease. The Wearables for Metabolic Health (WEAR-ME) pilot study will combine behavioral and biometric data from Fitbit devices with Quest Diagnostics' laboratory tests to enhance metabolic health assessment and management, aiding disease prevention.
In April 2023, Garmin Ltd. has extended regional availability of its Dexcom Connect IQ apps, specifically designed for Type 1 or Type 2 diabetes users. These apps allow users to monitor glucose levels and trends on compatible smartwatches or cycling computers. The announcement is expected to impact the wearable medical devices market, enhancing accessibility to glucose monitoring solutions.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global wearable medical devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Prevalence of Chronic Diseases and Health Awareness
4.2. Restraints
4.3. Opportunity
- 4.3.1. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 6.1.2. Market Attractiveness Index, By Product type
6.2. Diagnostic & Monitoring Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Therapeutic Devices

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Remote Patient Monitoring*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Sports and Fitness Monitoring
7.4. Chronic Disease Management
7.5. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals & Clinics*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Homecare Settings
8.4. Ambulatory Care Centers
8.5. Fitness Centers and Sports Institutes

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Koninklijke Philips N.V*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Garmin Ltd
11.3. Medtronic
11.4. Omron
11.5. Withings
11.6. VitalConnect
11.7. Polar Electro
11.8. Sotera, Inc
11.9. INVIZA Corporation
11.10. GE HealthCare

LIST NOT EXHAUSTIVE